First Trust Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-214,120
| Closed | -$3.07M | – | 2596 |
|
|
2025
Q1 | $3.07M | Buy |
214,120
+136,624
| +176% | +$2.13M | ﹤0.01% | 1578 |
|
|
2024
Q4 | $1.23M | Buy |
+77,496
| New | +$1.53M | ﹤0.01% | 1992 |
|
|
2024
Q2 | – | Sell |
-25,428
| Closed | -$506K | – | 2317 |
|
|
2024
Q1 | $506K | Sell |
25,428
-11,071
| -30% | -$214K | ﹤0.01% | 2145 |
|
|
2023
Q4 | $819K | Sell |
36,499
-51,540
| -59% | -$1.06M | ﹤0.01% | 2023 |
|
|
2023
Q3 | $1.78M | Buy |
88,039
+14,157
| +19% | +$321K | ﹤0.01% | 1732 |
|
|
2023
Q2 | $1.89M | Sell |
73,882
-13,824
| -16% | -$364K | ﹤0.01% | 1730 |
|
|
2023
Q1 | $2.61M | Buy |
87,706
+55,032
| +168% | +$1.6M | ﹤0.01% | 1566 |
|
|
2022
Q4 | $884K | Sell |
32,674
-13,172
| -29% | -$322K | ﹤0.01% | 2001 |
|
|
2022
Q3 | $999K | Sell |
45,846
-307
| -0.7% | -$8.02K | ﹤0.01% | 1998 |
|
|
2022
Q2 | $1.26M | Buy |
46,153
+28,610
| +163% | +$822K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $588K | Sell |
17,543
-11,123
| -39% | -$358K | ﹤0.01% | 2222 |
|
|
2021
Q4 | $994K | Buy |
+28,666
| New | +$927K | ﹤0.01% | 2056 |
|
|
2021
Q3 | – | Sell |
-41,383
| Closed | -$1.5M | – | 2517 |
|
|
2021
Q2 | $1.5M | Buy |
41,383
+24,461
| +145% | +$1.01M | ﹤0.01% | 1914 |
|
|
2021
Q1 | $740K | Buy |
16,922
+7,997
| +90% | +$375K | ﹤0.01% | 2076 |
|
|
2020
Q4 | $409K | Buy |
8,925
+635
| +8% | +$26.4K | ﹤0.01% | 2162 |
|
|
2020
Q3 | $275K | Buy |
+8,290
| New | +$265K | ﹤0.01% | 2179 |
|
|
2019
Q3 | – | Sell |
-8,940
| Closed | -$390K | – | 2396 |
|
|
2019
Q2 | $390K | Buy |
8,940
+1,409
| +19% | +$60.3K | ﹤0.01% | 2227 |
|
|
2019
Q1 | $321K | Buy |
7,531
+1,185
| +19% | +$53.1K | ﹤0.01% | 2254 |
|
|
2018
Q4 | $284K | Sell |
6,346
-1,962
| -24% | -$103K | ﹤0.01% | 2274 |
|
|
2018
Q3 | $569K | Sell |
8,308
-20,948
| -72% | -$1.35M | ﹤0.01% | 2160 |
|
|
2018
Q2 | $1.68M | Buy |
29,256
+11,837
| +68% | +$625K | ﹤0.01% | 1701 |
|
|
2018
Q1 | $803K | Sell |
17,419
-634
| -4% | -$30.1K | ﹤0.01% | 1870 |
|
|
2017
Q4 | $834K | Sell |
18,053
-1,143
| -6% | -$52.5K | ﹤0.01% | 1917 |
|
|
2017
Q3 | $864K | Sell |
19,196
-808
| -4% | -$34.5K | ﹤0.01% | 1903 |
|
|
2017
Q2 | $786K | Sell |
20,004
-7,830
| -28% | -$296K | ﹤0.01% | 1930 |
|
|
2017
Q1 | $1.06M | Sell |
27,834
-866
| -3% | -$33.7K | ﹤0.01% | 1835 |
|
|
2016
Q4 | $1.06M | Buy |
+28,700
| New | +$1.03M | ﹤0.01% | 1787 |
|
|
2016
Q1 | – | Sell |
-36,924
| Closed | -$1.23M | – | 2218 |
|
|
2015
Q4 | $1.23M | Buy |
+36,924
| New | +$1.15M | ﹤0.01% | 1652 |
|
|
2015
Q2 | – | Sell |
-55,852
| Closed | -$2.75M | – | 2237 |
|
|
2015
Q1 | $2.75M | Buy |
+55,852
| New | +$2.59M | 0.01% | 1316 |
|
Other funds holding AVNS
AC
PIM
ECM
First Trust Advisors's AVNS Position: Q2 2025 in Review
First Trust Advisors sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 214,120 shares — an estimated $3.07M sold.
First Trust Advisors first reported a position in AVNS in Q1 2015 and held it in 29 quarters. The position peaked at $3.07M in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.
- First Trust Advisors reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
- First Trust Advisors sold 214,120 Avanos Medical shares in Q2 2025, an estimated $3.07M.
- First Trust Advisors first reported a position in Avanos Medical in Q1 2015 and held it in 29 quarters.
- First Trust Advisors's Avanos Medical position peaked at $3.07M in Q1 2025.
- 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.
Based on First Trust Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.